Refine your search
5 trials found for Hemophilia, Haemophilia
Recruiting
Not yet recruiting
Recruiting
NCT05568719
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
Hemophilia A, Hemophilia B
Males
18+ years
12study location(s)
Recruiting
NCT06703606
A Study to Learn About How Changing Therapy From Emicizumab to Marstacimab Affects People With the Severe Hemophilia A.
Severe Hemophilia A
Males
12 - 74 years
1study location(s)
Recruiting
NCT05611801
A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
Hemophilia A, Hemophilia B
Males
1 - 17 years
69study location(s)
Recruiting
NCT05145127
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
Hemophilia A, Hemophilia B
Males
1 - 74 years
60study location(s)
Mar 17, 2025 - Planned start date (Not yet recruiting)
NCT06634836
Patient Interview Study to Explore the Impact of Gene Therapy in Hemophilia A & B
Hemophilia A, Hemophilia B
Males
18 - 85 years
Saved trials
Saved trials
You currently don’t have any saved trials. To save a trial, select the bookmark icon on the result listing.
Recruiting
Not yet recruiting
Contact us
For more information about participation in a Pfizer clinical trial, please email or call the Pfizer Clinical Trial Contact Center at 1-800-887-7002.